MAPT and Alzheimer disease: However, the recent Nature study (Aron et al., 2025) offers compelling validation of our model: lithium deficiency was shown to accelerate amyloid and tau pathology, microglial activation, and cognitive decline in AD mouse models, while lithium supplementation prevented these effects.